ID   NCI-H2009-Luc
AC   CVCL_4Y15
DR   JCRB; JCRB1529
DR   JCRB; NIHS0725
DR   Wikidata; Q54907902
CC   Sequence variation: Mutation; HGNC; 914; B2M; Simple; p.Met1Val (c.1A>G); ClinVar=VCV000376369; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 914; B2M; Simple; p.Gln28Ter (c.82C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg273Leu (c.818G>T); ClinVar=VCV000376655; Zygosity=Homozygous (from parent cell line).
CC   Transfected with: UniProtKB; P08659; Firefly luciferase.
CC   Discontinued: JCRB; NIHS0725; true.
CC   Derived from metastatic site: Lymph node.
ST   Source(s): JCRB
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 12
ST   D5S818: 13
ST   D7S820: 9,11
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens
HI   CVCL_1514 ! NCI-H2009
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 20-05-21; Version: 11
//